KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Interest Expenses (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Interest Expenses for 17 consecutive years, with $397.0 million as the latest value for Q4 2025.

  • Quarterly Interest Expenses rose 17.8% to $397.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Dec 2025, up 15.56% year-over-year, with the annual reading at $1.6 billion for FY2025, 15.56% up from the prior year.
  • Interest Expenses hit $397.0 million in Q4 2025 for Bausch Health Companies, down from $412.0 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $465.0 million in Q2 2025 to a low of $307.0 million in Q4 2022.
  • Historically, Interest Expenses has averaged $360.5 million across 5 years, with a median of $353.0 million in 2021.
  • Biggest five-year swings in Interest Expenses: dropped 22.2% in 2023 and later surged 32.86% in 2025.
  • Year by year, Interest Expenses stood at $343.0 million in 2021, then dropped by 10.5% to $307.0 million in 2022, then increased by 18.24% to $363.0 million in 2023, then decreased by 7.16% to $337.0 million in 2024, then increased by 17.8% to $397.0 million in 2025.
  • Business Quant data shows Interest Expenses for BHC at $397.0 million in Q4 2025, $412.0 million in Q3 2025, and $465.0 million in Q2 2025.